Concepedia

M Gierend

MG

Statistics

Publications

14

Citations

576

H-Index

13

Active since

1981

Affiliations

University of Regensburg(Current)

Saarland University

Medicomp (United States)

University Hospital Regensburg

M Gierend is an author at University of Regensburg specializing in pharmacotherapy, inflammatory bowel disease, and inflammatory bowel disease therapy.

Publications per year

1981–2004

14

Publications

14

Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.

T. Andus, I. Caesar, Sven Bischoff et al. · PubMed · 1996 · 110 citations

, , +13

Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease

Tilo Andus, K. W. Ecker, Andreas Raedler et al. · Gut · 1998 · 109 citations · Full text

, , +14

Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction

H-J Vogt, P Brandl, G. Kockott et al. · International Journal of Impotence Research · 1997 · 72 citations

, , +9

Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease

Cornelia M. Gelbmann, Gerhard Rogler, M Gierend et al. · The American Journal of Gastroenterology · 2002 · 56 citations

, , +15

Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.

Tilo Andus, Wolfgang Fischbach, Achim Weber et al. · PubMed · 1995 · 34 citations

, , +11

1–5 of 14